Compare iShares Core High Dividend ETF (HDV) vs Herbalife Nutrition Ltd (HLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Core High Dividend ETF vs Herbalife Nutrition Ltd — how do they compare? iShares Core High Dividend ETF trades at $28.7 (market cap $14.68B), while Herbalife Nutrition Ltd trades at $12.84 (market cap $1.34B). The key difference: iShares Core High Dividend ETF is far larger — about 11× Herbalife Nutrition Ltd's market cap, and iShares Core High Dividend ETF is trading nearer its 52-week high, Herbalife Nutrition Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core High Dividend ETF for 117 Days and Herbalife Nutrition Ltd for 43 Days on average.
| HDV | HLF | |
|---|---|---|
Market Cap | $14.68B | $1.34B |
Volume | 2,925,562 | 1,589,457 |
52-Week High | $29.93 | $19.96 |
52-Week Low | $23.64 | $7.75 |
Typical Hold Time | 117 Days | 43 Days |
Sector | — | Consumer Staples |
Enterprise Value | — | $3.18B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HDV (iShares Core High Dividend ETF) trades at $28.73, up 1.59% with strong bullish technical signals from moving averages and oscillators. The ETF recently underwent a significant sector rebalancing, reducing healthcare exposure while increasing energy, staples, and utilities. Recent dividend payments of $0.06-$0.10 per share demonstrate consistent income generation, though the 3% yield may not fully compensate for increased concentration risk.
The outlook remains cautiously optimistic given the bullish technical setup and sector rotation benefits, but investors face risks from heightened concentration in three sectors (62% allocation) and potential yield compression. The ETF's performance relative to peers like VYM suggests competitive positioning, though sector concentration requires monitoring for diversification adequacy.
HLF trades at $12.65, up 0.56% today, with a bullish technical signal from moving averages. The stock shows attractive valuation with a P/E of 8.22 and P/S of 0.26. Recent earnings were mixed, with a Q1 2026 beat but Q4 2025 and Q2 2026 misses. The company announced a $250 million share repurchase program and a CEO transition effective October 31, 2026. Cash flow trends show improvement, with 2026 projected net cash flow turning positive at $50 million.
The outlook is cautiously optimistic, supported by analyst consensus price target of $19.00 implying significant upside. Key opportunities include debt reduction progress and margin expansion plans. Risks include inconsistent earnings performance, high debt levels, and investor scrutiny following the CEO transition. The stock remains a value play if execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Core High Dividend ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.
Read more on HDV →About Herbalife Nutrition Ltd
Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →
